178 related articles for article (PubMed ID: 320261)
1. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
Haran-Ghera N; Ben-Yaakov M; Peled A
J Immunol; 1977 Feb; 118(2):600-6. PubMed ID: 320261
[TBL] [Abstract][Full Text] [Related]
2. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response.
Haran-Ghera N; Rubio N
J Immunol; 1977 Feb; 118(2):607-11. PubMed ID: 839072
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of potential lymphoma-inducing cells in mice sensitive or resistant to lymphomagenesis by radiation leukemia virus variants.
Gokhman I; Peled A; Haran-Ghera N
Cancer Res; 1990 May; 50(9):2554-61. PubMed ID: 2158393
[TBL] [Abstract][Full Text] [Related]
4. High- and low-leukemogenic variants of the radiation leukemia virus (RadLV): immunogenic, suppressive and genetic properties in relation to leukemogenic activity.
Yefenof E; Ben David Y; Kotler M
Int J Cancer; 1984 Dec; 34(6):875-82. PubMed ID: 6439654
[TBL] [Abstract][Full Text] [Related]
5. Immunity and suppression in radiation- and radiation leukemia virus (RadLV)-induced leukemogenesis.
Yefenof E; Ben-David Y
Leuk Res; 1986; 10(7):797-801. PubMed ID: 2942733
[TBL] [Abstract][Full Text] [Related]
6. The cellular basis of immunosuppression caused by the radiation leukaemia virus.
Peled A; Haran-Ghera N
Immunology; 1974 Feb; 26(2):323-9. PubMed ID: 4369273
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression by leukemia viruses. Effect of Friend leukemia virus on humoral immune competence of leukemia-resistant C57BL/6 mice.
Ceglowski WS; Campbell BP; Friedman H
J Immunol; 1975 Jan; 114(1 Pt 1):231-6. PubMed ID: 1089712
[TBL] [Abstract][Full Text] [Related]
8. Cellular events during radiation-induced thymic leukemogenesis in mice: abnormal T cell differentiation in the thymus and defect of thymocyte precursors in the bone marrow after split-dose irradiation.
Muto M; Kubo E; Sado T
J Immunol; 1985 Mar; 134(3):2026-31. PubMed ID: 3871460
[TBL] [Abstract][Full Text] [Related]
9. High- and low-leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor-specific immune suppression.
Yefenof E; Zilcha D
Int J Cancer; 1982 Sep; 30(3):355-9. PubMed ID: 6215365
[TBL] [Abstract][Full Text] [Related]
10. Macrophage and lymphocyte-depleted thymus reticuloepithelial cell cultures: establishment and functional influence on T-lymphocyte maturation, C-type virus expression and lymphomatous transformation in vitro.
Boniver J; Declève A; Dailey MO; Honsik C; Lieberman M; Kaplan HS
Thymus; 1981 Feb; 2(4-5):193-213. PubMed ID: 6262953
[TBL] [Abstract][Full Text] [Related]
11. Treatment of primary radiogenic C57BL mouse cell leukemia/lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy and adjuvant cellular therapy.
Maruyama Y; Feola JM; Kryscio R
Jpn J Cancer Res; 1985 Dec; 76(12):1236-43. PubMed ID: 3005211
[TBL] [Abstract][Full Text] [Related]
12. Radiation leukemia virus: a marker for the study of intrathymic T cell differentiation.
Boniver J; Delvenne C; Janowski M; Courtoy R; Defresne MP
Thymus; 1989; 14(1-3):109-13. PubMed ID: 2560269
[TBL] [Abstract][Full Text] [Related]
13. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
14. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
[TBL] [Abstract][Full Text] [Related]
15. Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic murine cells.
Ben-David Y; Yefenof E; Kotler M
Cancer Res; 1987 Dec; 47(24 Pt 1):6590-4. PubMed ID: 2824038
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterization of mice of thymus target cells susceptible to productive infection by the radiation leukemia virus.
Boniver J; Declève A; Honsik C; Lieberman M; Kaplan HS
J Natl Cancer Inst; 1981 Nov; 67(5):1139-51. PubMed ID: 6117669
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic class.
Nakayama E; Uenaka A; DeLeo AB; Stockert E; Obata Y; Ueda R; Inui Y
J Immunol; 1986 May; 136(9):3502-7. PubMed ID: 3007622
[TBL] [Abstract][Full Text] [Related]
18. Leukemogenesis in vitro induced by thymus epithelial reticulum cells transmitting murine leukemia viruses.
Haas M; Sher T; Smolinsky S
Cancer Res; 1977 Jun; 37(6):1800-7. PubMed ID: 192463
[TBL] [Abstract][Full Text] [Related]
19. The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis.
Haran-Ghera N; Peled A; Wu L; Shortman K; Brightman BK; Fan H
Leukemia; 1995 Jul; 9(7):1199-206. PubMed ID: 7630195
[TBL] [Abstract][Full Text] [Related]
20. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
Seddik M; Seemayer TA; Lapp WS
Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
